[144] CryoPort, Inc. SEC Filing

Rhea-AI Filing Summary

CryoPort, Inc. (CYRX) Form 144 notice reports a proposed sale of 25,000 common shares through Morgan Stanley Smith Barney with an aggregate market value of $242,737.50, to be sold approximately on 09/11/2025 on NASDAQ. The shares were acquired and will be sold the same day pursuant to an exercise of options under a registered plan. The filing also records a prior sale by Robert Hariri of 5,000 shares on 08/22/2025 for $43,000. The filer certifies no undisclosed material information.

Positive

• Clear compliance with Rule 144 including broker, shares, pricing, and acquisition details
• Transaction is an exercise under a registered plan, indicating routine option monetization rather than unexplained transfers
• Filer attests no undisclosed material information, supporting disclosure transparency

Negative

• Insider sale disclosed (25,000 shares, $242,737.50) which some investors may view negatively despite modest size
• Prior sale by an insider (Robert Hariri sold 5,000 shares for $43,000 on 08/22/2025), indicating recent insider selling activity

Insights

Securities Analyst

TL;DR Routine insider option exercise and planned sale; modest in size relative to outstanding shares.

The notice documents an insider exercise-and-sell transaction of 25,000 shares valued at $242,737.50, with the shares to trade on NASDAQ and an outstanding share count shown as 50,066,968. From a market-impact perspective this quantity represents a small fraction of total shares outstanding and is consistent with option monetization rather than large-scale divestment. The filing follows Rule 144 disclosure requirements and includes a recent smaller sale of 5,000 shares for $43,000 by Robert Hariri.

Corporate Governance Expert

TL;DR Disclosure appears compliant; transaction is an exercise under a registered plan and was reported via Form 144.

The Form 144 provides the required details: broker name and address, acquisition date, nature of acquisition (exercise of options under a registered plan), and aggregate market value. The filer attests there is no material nonpublic information. This is standard governance practice for insiders monetizing option exercises, and the filing helps maintain transparency with investors.

09/11/2025 - 04:29 PM

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	25000	242737.50	50066968	09/11/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/11/2025	Exercise of options under a registered plan	Issuer			25000	09/11/2025	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Robert Hariri 112 Westwood Place, Suite 350 Brentwood TN 37027	Common	08/22/2025	5000	43000.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does CryoPort's (CYRX) Form 144 filed here report?

The filing reports a proposed sale of 25,000 common shares via Morgan Stanley Smith Barney with an aggregate market value of $242,737.50, approximately on 09/11/2025 on NASDAQ.

How were the 25,000 CryoPort shares acquired according to the filing?

The shares were acquired on 09/11/2025 through an exercise of options under a registered plan, and the same date is listed for the acquisition and intended sale.

Did any insider recently sell CryoPort shares before this filing?

Yes. The filing records that Robert Hariri sold 5,000 shares on 08/22/2025 for $43,000.

Which broker is handling the planned sale in the Form 144?

The broker listed is Morgan Stanley Smith Barney LLC, Executive Financial Services, 1 New York Plaza, 8th Floor, New York, NY 10004.

What does the filer state about material nonpublic information?

By signing the notice the person represents they do not know any material adverse information about the issuer that has not been publicly disclosed.